Prospectus
Filed with ASX · · 32 pages · English
Summary by 6ix AI
EVE Health Group Limited has issued a prospectus detailing several offers to raise funds through the issuance of shares and options. The company plans to offer placement shares, placement options, and director placement shares, among others, to various subscribers. The prospectus outlines the terms of these offers, including pricing and conditions for shareholder approval. The funds raised will be used for corporate purposes as specified in the document.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/prospectus-176
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- EVE Placement Update
- EVE Raises $0.9m to Advance Drug Reformulation Strategy
- Trading Halt
- EVE Advances Reformulated Drugs Targeting Global Markets
- Appendix 4D and Half Year Report
Later from EVE Health
- Investor Presentation
- Appointment of Chief Executive Officer
- Eve Initiates Pilot Clinical Study for Libbo ED Film
- Quarterly Activities/Appendix 4C Cash Flow Report - Amended
- Response to ASX Price and Volume Query
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health